• NU7441 (KU-57788): Precision DNA-PK Inhibition in Oncology

  2026-07-14

  NU7441 (KU-57788) offers nanomolar-range, highly selective DNA-PK inhibition, enabling robust DNA repair and oncology research. Its combination of specificity, workflow flexibility, and translational relevance—exemplified by its role in dissecting immune escape in gastric cancer—distinguishes it as a cornerstone compound for advancing cell cycle and DNA damage studies.

• Fra2/LCN2 Axis Drives PM2.5-Linked Asthma via Macrophage Fer

  2026-07-14

  This study identifies the Fra2/LCN2 pathway as a critical mechanism linking PM2.5 exposure to asthma exacerbation through induction of ferroptosis in M2 macrophages. Targeted disruption of this pathway mitigates airway inflammation and dysfunction, offering a new therapeutic angle for environment-associated asthma and advancing our understanding of iron metabolism in immune cells.

• Cell lysis buffer for WB and IP: Precision Protein Extractio

  2026-07-13

  Cell lysis buffer for WB and IP enables efficient, non-denaturing protein extraction for Western blot and immunoprecipitation. Its optimized inhibitor cocktail preserves protein interactions, minimizing degradation and supporting robust tumor microenvironment proteomics.

• WST-8 Glucose Uptake Assay Kit: Precision Metabolic Profilin

  2026-07-13

  Explore the WST-8 Glucose Uptake Assay Kit for highly sensitive, non-radioactive quantification of cellular glucose uptake. This article reveals advanced scientific insights, including ion supplementation strategies, and positions the kit as a cornerstone technology for metabolic research.

• Bifidobacterium vs. FMT in Hepatic Encephalopathy: Neuroinfl

  2026-07-12

  This study evaluates the efficacy of Bifidobacterium and fecal microbiota transplantation (FMT) in reducing neuroinflammation in a rat model of chronic hepatic encephalopathy using [18F]PBR146 PET imaging. It demonstrates that Bifidobacterium, but not FMT, significantly inhibits neuroinflammatory signals in specific brain regions, providing new perspectives on targeted interventions for gut–liver–brain axis modulation.

• RG7388: Redefining p53 Pathway Activation in Translational O

  2026-07-10

  RG7388 (MDM2 antagonist, oral, selective) is revolutionizing the landscape of p53-targeted cancer research. This article explores its mechanistic edge, translational workflows, and future-ready strategies for optimizing apoptosis induction and overcoming chemoradiotherapy resistance, with evidence integration from recent biomarker studies and advanced experimental paradigms.

• Self-Assembling Virus-Mimicking Particles for Extrahepatic m

  2026-07-09

  This study details the engineering of a self-assembling enveloped virus-mimicking particle (EVMP) platform, achieving efficient and targeted delivery of mRNA to extrahepatic organs such as the lung and spleen. By addressing longstanding barriers of tissue specificity, immunogenicity, and manufacturability, the work establishes a modular strategy for advancing mRNA therapeutics beyond hepatic applications.

• Distinct Vascular Effects of JAK Inhibitors in Endothelial I

  2026-07-09

  This study systematically compares the vascular actions of approved JAK inhibitors—including tofacitinib citrate—on human endothelial cells exposed to proinflammatory cytokines. The findings reveal nuanced differences in cytokine suppression, adhesion molecule modulation, and cytotoxicity, refining our understanding of cardiovascular risk and immune regulation in inflammatory disease models.

• Polygodial as a TRPA1 Channel Activator: Protocols & Insight

  2026-07-08

  Polygodial from APExBIO delivers reliable, selective activation of TRPA1 channels, enabling high-fidelity studies in sensory neuron and membrane transporter signaling. This article distills validated workflows, advanced use-cases, and troubleshooting tips—translating recent mechanistic discoveries into practical research strategies.

• Hypoxia and Immunometabolism: Mechanisms in Tumor Progressio

  2026-07-08

  This review elucidates how hypoxia-driven metabolic reprogramming and immune adaptation shape the tumor microenvironment (TME), enabling cancer progression and immune evasion. It synthesizes mechanistic insights and therapeutic implications, emphasizing the interplay between nutrient competition, immune cell function, and tumor survival strategies.

• Ceapin-A7: Selective ER Stress Blocker for Pathway Dissectio

  2026-07-07

  Ceapin-A7 empowers researchers to untangle the ATF6α arm of the unfolded protein response with precision, enabling targeted studies of ER stress signaling in disease models. This guide details stepwise protocols, troubleshooting strategies, and key insights on applying Ceapin-A7 for advanced endoplasmic reticulum stress research.

• Applied Use-Cases of 5-Aminolevulinic acid HCl in Heme Biosy

  2026-07-07

  5-Aminolevulinic acid HCl empowers precise studies of heme biosynthesis and immune evasion at the bench, bridging infection biology with translational cancer research. Explore advanced protocols, troubleshooting insights, and the latest mechanistic breakthroughs driving reproducibility with APExBIO’s high-purity 5-ALA HCl.

• Ricin-Induced Necroptosis and Bystander Inflammation in Lung

  2026-07-06

  Kempen et al. (2023) reveal that ricin toxin not only directly induces cell death in lung epithelial cells but also triggers necroptosis through bystander inflammatory mechanisms involving monocytic cell-derived factors. These findings clarify the interplay of apoptosis, necroptosis, and inflammatory signaling in toxin-mediated lung injury and suggest new experimental avenues for apoptosis and pyroptosis research.

• Targeted EPO mRNA Nanoparticles Suppress Ferroptosis in SCI

  2026-07-06

  This study demonstrates an inflammation-targeted lipid nanoparticle system for the delivery of human erythropoietin mRNA to injured spinal cord tissue. The approach modulates both neuroinflammation and ferroptotic cell death, leading to improved neurological outcomes and providing a mechanistically grounded platform for mRNA-based neurorepair strategies.

• Tacrolimus (FK506): Applied Immune Modulation Workflows

  2026-07-05

  Tacrolimus (FK506) stands apart as a high-potency, selective immunosuppressant for dissecting T-cell activation and cytokine signaling in transplantation and autoimmune disease models. This guide distills evidence-backed protocols, troubleshooting strategies, and actionable workflow tips, enabling robust and reproducible immune modulation in experimental systems.

460 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page